Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | RECQL | P46063 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | APEX1 | P27695 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | AURKA | O14965 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8163496 | 0.79 | HPGD (0.39) | ALDH1A1ALOX15HSD17B10TDP1MAPT | |
| SCHEMBL17265007 | 0.71 | METAP2 (0.44) | ALDH1A1ALOX15HSD17B10TDP1MAPT | |
| SCHEMBL1930706 | 0.71 | — | — | |
| SCHEMBL10067984 | 0.69 | GSK3B (0.48) | ALDH1A1ALOX15TDP1MAPTCYP3A4 | |
| SCHEMBL20799548 | 0.68 | ACHE (0.38) | — | |
| SCHEMBL14279991 | 0.68 | ESR1 (0.42) | ALDH1A1ALOX15HSD17B10MAPTHPGD | |
| SCHEMBL3807753 | 0.67 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2NPC1NFKB1RAB9A | |
| SCHEMBL14401600 | 0.67 | — | — | |
| SCHEMBL20861102 | 0.67 | KDM4E (0.32) | ALDH1A1HSD17B10TDP1MAPTHPGD | |
| SCHEMBL23318985 | 0.66 | TRPA1 (0.42) | ALDH1A1ALOX15HSD17B10TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4126800-A1 | TERPENOPHENOLIC COMPOUNDS AND THEIR USE | PHYTOTHERAPEUTIX LTD (GB) | 2023-02-08 | — | — | EP | claimed |
| WO-2021198692-A1 | TERPENOPHENOLIC COMPOUNDS AND THEIR USE | PHYTOTHERAPEUTIX LTD (GB) | 2021-10-07 | — | — | WO | claimed |
| US-20240050453-A1 | WATER-SOLUBLE CANNABINOID FORMULATION AND PREPARATION METHOD THEREFOR | HANYI BIOTECHNOLOGY (BEIJING) CO., LTD (CN) | 2024-02-15 | — | — | US | disclosed |
| US-20240018079-A1 | METHOD FOR PURIFYING CANNABINOID COMPOUNDS | CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) | 2024-01-18 | — | — | US | disclosed |
| WO-2023193244-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | 北京睿创康泰医药研究院有限公司 | 2023-10-12 | — | — | WO | disclosed |
| CN-114748434-B | Cannabinoid effervescent tablet and preparation method thereof | 汉义生物科技（北京）有限公司 | 2023-06-16 | — | — | CN | disclosed |
| EP-3847148-A2 | CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES | Purisys LLC (US) | 2021-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018079-A1 | METHOD FOR PURIFYING CANNABINOID COMPOUNDS | CNR2, CNR1, FAAH | ALDH1A1 2567/4885ALOX15 1567/4885HSD17B10 2759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.